Industry News
Borealis-2 Clinical Trial Evaluating OGX-427 In Combination With Second-Line Therapy For Bladder Cancer Announced
Feb 13, 2013
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) has announced plans for the initiation of the Borealis-2 clinical trial, an investigator-sponsored, randomized, controlled Phase 2 study evaluating OGX-427 in patients with advanced or metastatic bladder cancer who have disease progression following initial platinum-based chemotherapy treatment... Read More
2013 Genitourinary Cancers Symposium: New Insights Into High-Risk Prostate Cancer; Management Of Small Kidney Tumors
Feb 13, 2013
Research on promising new therapies and data on the relative benefits of established treatments for genitourinary cancers were released, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 14-16, 2013, at the Rosen Shingle Creek in Orlando, FL... Read More
2013 Genitourinary Cancers Symposium: New Insights Into High-Risk Prostate Cancer; Management Of Small Kidney Tumors
Feb 13, 2013
Research on promising new therapies and data on the relative benefits of established treatments for genitourinary cancers were released, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 14-16, 2013, at the Rosen Shingle Creek in Orlando, FL... Read More
Rethink Of How Ovaries Develop
Feb 13, 2013
New research from the University of Adelaide will rewrite the textbooks on how an ovary is formed, as well as providing new insights into women's health and fertility. The study, now published in the journal PLOS ONE, also names a new type of cell that plays a key role in the development of ovaries and ovarian follicles, which are responsible for the production of eggs in women... Read More
New Strategy Identified For Interfering With A Potent Cancer-Causing Gene
Feb 13, 2013
Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics. CSHL Assistant Professor Christopher Vakoc, M.D., Ph.D... Read More
The Therapeutic Effect Of RNAi Gene Silencing In Cancer Treatment
Feb 13, 2013
The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving three Spanish and six American research centres, presents significant results in treating cancer patients with nanoparticles containing ribonucleic acid interference (RNAi) molecules... Read More
Rethink Of How Ovaries Develop
Feb 13, 2013
New research from the University of Adelaide will rewrite the textbooks on how an ovary is formed, as well as providing new insights into women's health and fertility. The study, now published in the journal PLOS ONE, also names a new type of cell that plays a key role in the development of ovaries and ovarian follicles, which are responsible for the production of eggs in women... Read More
New Strategy Identified For Interfering With A Potent Cancer-Causing Gene
Feb 13, 2013
Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics. CSHL Assistant Professor Christopher Vakoc, M.D., Ph.D... Read More
Genetic Root To Early-Onset Prostate Cancer Identified
Feb 13, 2013
Prostate cancer is often considered an elderly man's disease, and little is known about the approximately 2% of cases that arise in men who are aged 50 years or younger. Research published in Cell Press journal Cancer Cell uncovers the genetic origin of such early-onset prostate cancer... Read More
Improved Treatment Alternative For Lymphoid Leukemia Suggested By International Study
Feb 13, 2013
Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models... Read More
Previous Page Next Page